Zolgensma and Seven Other Products Get CHMP Thumbs Up

Zolgensma should receive a conditional approval, says the European Medicines Agency’s drug evaluation committee, the CHMP.

Gene editing genes therapy concept with nurse and DNA lab technician medical laboratory
A gene therapy for spinal muscular atrophy has moved closer to the EU market • Source: Shuuterstock

More from Europe

More from Geography